- Forbes•15 hours ago
The Supreme Court's recent ruling in Life Technologies v. Promega is likely to bring back that staple of the global supply chain: liquidated damages clauses in contracts.
- American City Business Journals•2 days ago
The U.S. Supreme Court on Wednesday ruled in favor of a subsidiary of Waltham-based Thermo Fisher Scientific in a patent case with broad implications for device makers that use global supply chains. In a unanimous decision, the court ruled that a genetic testing kit made by Life Technologies, which Thermo Fisher (TMO) purchased in 2013, did not infringe patents held by Wisconsin-based Promega Corp. Life Technologies made one important component of the kit in the U.S., then sent it to a U.K. facility to be completed.
- Reuters•3 days ago
The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision. The justices ruled 7-0 that the subsidiary, Life Technologies Corp, could not be held liable for violating the patent by shipping one part of a testing kit from the United States to Britain, where it was assembled with other components and sold overseas. California-based Life Technologies and privately held Wisconsin-based Promega both sell DNA testing kits for forensic identification, paternity testing, medical research and other uses.
TMO : Summary for Thermo Fisher Scientific Inc Co - Yahoo Finance
Thermo Fisher Scientific Inc. (TMO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||157.58 - 158.98|
|52 Week Range||129.13 - 160.68|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||31.23|
|Dividend & Yield||0.60 (0.38%)|
|1y Target Est||N/A|